The National Institute of Neurological Disorders and Stroke (NINDS) invites small business innovation research (SBIR) and small business technology transfer (STTR) applications to develop new technology for proteomics and glycomics. This announcement is made together with 3 other components of the National Institutes of Health (NIH).*
Proteomics is a rapidly expanding field. Proteomic technologies and methods remain largely inadequate, particularly with respect to quantitative and real-time measurements. Novel approaches and tools are needed to address the technical challenges in proteomics, and the special challenges of glycobiology-focused proteomics, or glycomics.
This announcement encourages grant applications from small businesses to develop broadly applicable research tools that address the core technical challenges in proteomics and glycomics including, but not limited to: robotics, sample preparation and pre-fractionation, analytical separations, gel and array imaging, quantitation, mass spectrometry, intelligent automated data acquisition, and improved informatics technologies. One area of particular interest is the development of technologies that will permit quantitative and real-time observations, for either clinical studies or experimental systems.
For more information, potential applicants should contact Dr. Danilo Tagle, Program Director, Neurogenetics Group, NINDS, Neuroscience Center, 6001 Executive Boulevard, Room 2133, Bethesda, MD 20892; telephone: 301-496-5745; fax: 301-402-1501; e-mail: email@example.com.
*For a full list of supporting NIH components and a more detailed description of this announcement, please visit the NIH web site at: http://grants.nih.gov/grants/guide/pa-files/PA-06-128.html (SBIR) or http://grants.nih.gov/grants/guide/pa-files/PA-06-129.html (STTR).